Phosplatin Therapeutics
VerifiedPhosplatin Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$148—222m (Dealroom.co estimates Dec 2021.)
New York City New York (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
* | $37.0m | Series A | |
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about Phosplatin Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.